Core Insights - HCA Healthcare, Inc. is a significant player in the healthcare services sector with a market capitalization of $107.7 billion and is set to announce its fiscal Q4 earnings for 2025 soon [1] Financial Performance - Analysts anticipate HCA to report a profit of $7.37 per share for the upcoming quarter, reflecting an 18.5% increase from $6.22 per share in the same quarter last year [2] - For the current fiscal year ending in December, HCA is expected to achieve a profit of $27.60 per share, which is a 25.7% increase from $21.96 per share in fiscal 2024, with further growth projected to $29.66 per share in fiscal 2026 [3] Stock Performance - HCA's shares have increased by 55.5% over the past 52 weeks, significantly outperforming the S&P 500 Index's 16% return and the State Street Health Care Select Sector SPDR ETF's 12.5% increase during the same period [4] Recent Developments - Following a better-than-expected Q3 earnings release, HCA's shares rose by 1.6%. The company reported total revenue of $19.2 billion, a 9.6% year-over-year increase, exceeding consensus expectations by 3.6%. Adjusted EPS improved by 42% from the previous year to $6.96, surpassing analyst estimates of $5.65 [5] - HCA has raised its fiscal 2025 guidance, now expecting revenue between $75 billion and $76.5 billion, and EPS between $27 and $28 [5] Analyst Ratings - Wall Street analysts maintain a "Moderate Buy" rating for HCA, with 14 out of 25 analysts recommending "Strong Buy," one suggesting "Moderate Buy," nine indicating "Hold," and one advising "Strong Sell." The mean price target for HCA is $486.41, suggesting a 3% potential upside from current levels [6]

Core Insights - HCA Healthcare, Inc. is recognized as one of the top medical stocks to invest in currently, with a Buy rating and a price target of $444.00 set by Cantor Fitzgerald [1] Financial Performance - HCA Healthcare reported a revenue growth of 6.4% for fiscal Q2 2025, reaching $18.605 billion, while net income increased by 13.1% to $1.653 billion [2] - The diluted EPS rose by 23.5% to $6.83 per diluted share, and the adjusted diluted EPS grew by 24.4% to $6.84 per diluted share [2] - Adjusted EBITDA also saw an increase of 8.4%, amounting to $3.849 billion [2] Company Overview - HCA Healthcare operates a diverse range of healthcare services, including hospitals, urgent care facilities, freestanding surgery centers, emergency care facilities, diagnostic and imaging centers, walk-in clinics, and radiation and oncology therapy centers [3]